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Intracellular free Ca2+ concentrations [Caz+], were measured in ovine anterior pituitary cells using the quin 
2 technique. Thyrotropin-releasing hormone (TRH) increased, dopamine decreased and growth hormone- 
releasing hormone (GHRH) had no detectable ffect on [Caz+],. Loading the cells with quin 2, at an intracel- 
lular concentration less than that used during calcium determination, reduced both basal growth hormone 
(GH) and (to a small extent) prolactin secretion. Loading cells with quin 2 also markedly reduced GHRH- 
stimulated GH secretion. However, TRH-stimulated prolactin secretion was 3-times basal irrespective of 
quin 2 loading. The results indicate that the use of quin 2 to measure [Ca*+], in some ceil types may be 
complicated by actions of quin 2 on cellular function. 
Quin 2 Thyrotropin-releasing hormone Dopamine Growth hormone-releasing hormone 
(Ovine pituitary cell) Caz’ Growth hormone Prolactin Hormone secretion 
1. INTRODUCTION 
The fluorescent indicator quin 2 has been used 
extensively to measure intracellular free calcium 
concentrations ([Ca”],) in rat pituitary tumour 
(GH) cells [l-3] and bovine anterior pituitary cells 
[4]. These studies suggest that TRH, a potent 
stimulator of prolactin secretion [5], elevates 
[Ca’+]i [l-4] and that dopamine, an inhibitor of 
prolactin secretion [6], lowers [Ca2+]i [4]. The 
[Ca’+]i response to TRH has been most fully 
characterized [l-4], 
Quin 2, whose structure resembles EGTA, is 
added to a cell suspension in its ester form (quin 2 
acetoxymethyl ester; quin 2/AM) which is readily 
Abbreviations: TRH, thyrotropin-releasing hormone; 
GHRH, growth hormone-releasing hormone; GH, 
growth hormone; HIM buffer, Hepes-buffered incuba- 
tion medium; [Ca2+11, intracellular free Ca2+ 
concentration 
taken into the cells. It is subsequently hydrolysed 
by non-specific esterases within the cell and 
trapped. When quin 2 binds intracellular calcium 
its fluorescence increases, and changes in [Ca’+]i 
can therefore be calculated by measuring changes 
in fluorescence. However, the effect of loading 
normal pituitary cells with quin 2 has not been well 
characterized, particularly with respect to actions 
on secretion. 
Here we show, using the quin 2 technique, that 
TRH elevates and dopamine lowers [Ca2+]i in 
ovine anterior pituitary cells. GHRH, a potent 
stimulator of GH secretion (whose action is 
mediated primarily via the intracellular second 
messenger cyclic AMP [7,8]) had no detectable ef- 
fect on [Ca2+]i. However, we also report that 
loading ovine pituitary cells with quin 2, at an in- 
tracellular concentration lower than that used dur- 
ing [Ca’+]i determinations, has specific and differ- 
ing effects on basal and stimulated GH and prolac- 
tin secretion. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Quin 2/AM (Sigma (London), Poole, England) 
was dissolved in dimethyi sulphoxide at 5 mM and 
stored at - 20°C over desiccant. Synthetic GHRH 
(44-NH*) was from Universal Biologicals, Cam- 
bridge. TRH and dopamine were from Sigma. 
2.2. Quin 2 fluorescence xperiments 
Ovine anterior pituitary cells were prepared ac- 
cording to [9]. Glands were dispersed (75 min, 
37°C) using collagenase (Boehringer, 3 mg/ml), 
hyaluronidase (Sigma, type-1s; I mg/mI) and 
deoxyribonuclease I (Boehringer, grade II; 
0.25 mg/ml) in medium containing bovine serum 
albumin (Sigma fraction V; 30 mg/ml), NaCl 
(137 mM), KC1 (5 mM), NazHP04 (0.7 mM), 
glucose (10 mM) and Hepes (25 mM) which was 
adjusted to pH 7.4 with NaOH. Cells were col- 
lected by centrifugation (1600 rpm, 3 min) and 
washed 5 times. Dispersed cells were plated (5 x 
lo6 cells/dish) into 5 cm bacteriological grade 
plates (Sterilin) and incubated in Dulbecco’s 
modified Eagle medium (15 ml/dish) containing 
5% foetal calf serum, 10% horse serum and an- 
tibiotics [9]. Under these conditions cell viability is 
maintained but cells do not attach. After 48 h at 
37°C under 95% air/W0 CO2 cells were pelleted 
and resuspended 3 times in a Hepes-buffered in- 
cubation medium (HIM) containing NaCl 
(125 mM), KC1 (5 mM), CaC12 (1.5 mM), MgClz 
(1 mM), KHzPOj (1 mM), NaHCOj (3.5 mM), 
Hepes (25 mM) and glucose (10 mM) which was 
adjusted to pH 7.4 with NaOH. 
About 20 x lo6 cells were incubated in 5 ml 
HIM buffer containing 20~zM quin 2/AM for 
45 min at 37°C with occasional agitation. The cells 
were then recovered by centrifugation, rinsed twice 
and resuspended in 10 ml HIM plus bovine serum 
albumin (0.1 mg/ml). The fluorescence of the cell 
suspension was measured using a Perkin Elmer 
LS-3 fluorimeter (h emission = 492 nm, A excita- 
tion = 338 nm) at 37°C with stirring. After addi- 
tion of test substances the fluorescence 
measurements were converted into ]Ca2’], using 
the calibration procedure in [lo]. Digitonin 
(20 PM) was added to lyse the cells and determine 
the fluorescence when all of the quin 2 in the cells 
was bound to CaZC (q uin 2 - Ca’+) (Max). EGTA 
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(1.5 mM, pH > 8) was then added to determine the 
fluorescence of unbound quin 2 (Fmin). The con- 
centrations of quin 2 trapped intracellularly were 
measured by comparing the fluorescence of total 
bound quin 2 (&,ax) with a standard curve con- 
structed with quin 2 (allowance being made for cell 
autofluorescence). The cell volume was estimated 
to be 0.697 pi/lo6 cells by measuring the average 
cell diameter. 
Corrections were made for the increase in 
fluorescence on addition of digitonin to unloaded 
cells. None of the test substances altered the 
fluorescence of unloaded cells. 
2.3. Secretion experiments 
Cells were dispersed, as in section 2.2, and main- 
tained in culture (1 x lo6 cells/dish) in 3.5 cm 
tissue culture plates (Sterilin) in 3 ml Dulbecco’s 
modified Eagle medium with Solo foetal calf serum, 
10% horse serum and antibiotics. After 72 h the 
incubation medium was removed, and the cells 
(which had attached to the plates) were rinsed 3 
times with HIM buffer and incubated in 1 ml HIM 
buffer with or without quin 2/AM for 45 min at 
37’C. The medium was discarded, the cells rinsed 
3 times with HIM buffer and incubated for 60 min 
with 1 ml HIM buffer + 0.1 mg/ml bovine serum 
albumin with or without test substances. At the 
end of the incubation period medium was removed 
and centrifuged and the supernatants were stored 
at - 20°C. Media were assayed for GH and prolac- 
tin using radioimmunoassay procedures as de- 
scribed in [9]. Hormones were iodinated using the 
iodogen method of Fraker and Speck [l 11. All 
samples and standards were dissolved in buffer 
containing sodium phosphate (0.05 M, pH 7.6), 
merthiolate (0.6 mM), bovine serum albumin 
(0.05~0) and Tween 20 (0.05~0). 
The concentrations of quin 2 trapped in- 
tracellularly were measured, as in section 2.2, by 
comparing the fluorescence of loaded cells, 
scraped from the culture dishes and lysed with 
digitonin, with a standard curve constructed with 
quin 2 (allowance being made for cell 
autofluorescence). 
2.4. Treatment of results 
All experiments were performed at least twice, 
with different preparations of pituitary cells, and 
consistent results were obtained. Experimental 
values are shown as means t SE and were com- 
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pared with controls for determination of statistical 
significance using Student’s t-test. 
3. RESULTS 
3.1. [Cd?+/i determinations 
The basal level of [Ca2+]l in cultured ovine 
anterior pituitary cells, estimated from the basal 
level of quin 2 fluorescence, corresponded to 310 
k 35 nM (mean f SE, n = 12). TRH (0.01 PM) 
stimulated a rapid increase in fluorescence over 
10 s corresponding to a doubling of [Ca”], to 208 
+- 16% (n = 3) of basal (fig.lA). [Ca”], levels re- 
mained elevated for at least 10 min. Subsequent 
addition of dopamine (0.01 $M) after TRH caused 
Fig. 1. Changes in quin 2 fluorescence observed in ovine 
anterior pituitary cells treated with various secreta- 
gogues. Cells were cultured overnight and incubated 
with 20fiM quin 2/AM for 45 min at 37°C; the 
fluorescence was then measured (A emission = 492 nm, 
h excitation = 338 nm). (A) TRH (0.01 PM) was added, 
followed by dopamine (DA, 0.01 ,uM) and then K+ 
(25 mM). (B) Dopamine (0.01 PM) was added, followed 
by TRH (0.01 PM) and then K+ (25 mM). (C) GHRH 
(1 nM) was added. In each experiment an estimate of 
fluorescence was finally obtained after lysis of cells by 
digitonin (DIG, 20 PM) (when all quin 2 present would 
become bound to Ca’+) and then in the presence of 
EGTA (when all quin 2 present would be dissociated 
0 0.1 1 .o IO 1’00 
( QUIN 2/AM 1 ( (rM ) 
Fig.2. Effect of incubating cultured sheep pituitary cells 
with increasing concentrations of quin 2/AM (O-30 PM) 
on basal and stimulated growth hormone (top) and 
prolactin (bottom) secretion. After incubation with quin 
2/AM for 45 min cells were rinsed and treated with 
0.1 nM GHRH (m), 0.1 PM TRH (A) or no additions 
(0). Error bars indicate f SE; where no bar is shown 
from Ca’+). Time is shown on the abscissa. SE falls within the limits of the symbol. 
a slow decrease in [Ca2+]i to reach 88 f 16% (n = 
2) of basal over a period of about 1 min. 
Dopamine alone caused a slow decrease in 
[Ca’+]i (fig.lB) over several minutes to 61 + 3% 
(n = 3) of basal. [Ca2+]i remained at this level for 
at least 10 min. Subsequent addition of TRH 
(0101 PM) after dopamine caused a rapid increase 
in [Ca’+]i to 102 + 10% (n = 4) of basal. GHRH 
(1 nM) had not detectable effect on [Ca’+]i 
(fig. 1C). 
The intracellular quin 2 concentration during 
these measurements was estimated to be 2.14 mM 
using the method described in section 2.2. 
3.2. Effects of loading cells with quin 2 on 
secretion of GH and prolactin 
The effects of various quin 2/AM concentra- 
tions (O-30pM) on basal and stimulated GH and 
prolactin secretion are shown in fig.2A and B. 
Loading cells with increasing concentrations of 
quin 2 caused a slight, but not significant, reduc- 
tion in basal prolactin secretion and a small but 
GROWTH HORMONE 
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significant reduction in TRH-stimulated secretion. 
However, TRH (0.1 PM) significantly stimulated 
prolactin release 3-fold, irrespective of quin 2 
loading (P < 0.01). 
Loading cells with increasing concentrations of 
quin 2 reduced basal GH secretion in a dose- 
dependent manner. Cells incubated with 30/rM 
quin 2/AM released 60% less GH than unloaded 
cells (P < 0.01). Incubating cells with 30pM quin 
2/AM also reduced GHRH (0.1 nM)-stimulated 
GH secretion from 9-times basal to 4-times basal 
(P < 0.001 vs unloaded cells). The intracellular 
[quin 21 during these experiments was estimated to 
be 1.2 mM, on incubation with 30 PM quin 2/AM 
as described in section 2.3. 
4. DISCUSSION 
4.1. /Cd’/, determinations 
Our data, using cultured ovine pituitary cells, 
show a basal [Ca’+]i of 310 +_ 35 nM compared 
with 210 f 20 nM reported using bovine anterior 
pituitary cells [4]. Basal [Ca’+]i reported for the rat 
pituitary tumour-derived cells (GH cells) varied 
considerably: 118 f 18 nM [I], 350 f 80 nM [2], 
195 + 10 nM [3], 148 f 8.6 nM [12]. 
Our data show clearly a rapid increase in [Ca’+]i 
in response to TRH and a slow decrease in [Ca’+]i 
in response to dopamine. The results are similar to 
those obtained by Schofield [4] using bovine cells. 
The biphasic response induced by TRH reported in 
rat pituitary tumour-derived cells [2] was not 
observed. The data also show that dopamine 
(0.01 PM) lowers the TRH (0.01 PM)-induced 
elevation of [Ca2+], to near basal levels, as has 
been reported using bovine cells [4]. 
Our data also show no detectable effect of 
GHRH on [Ca2+]i based on quin 2 fluorescence. 
This is interesting in view of a recent report that 
GHRH produces a significant stimulation of 
calcium efflux, with GH release, from perifused 
rat anterior pituitary cells [ 131. Calcium has been 
shown to be required for the actions of GHRH on 
release of GH [7,14]. It should be noted, however, 
that our dispersed ovine pituitary preparation is 
heterogeneous and contains only 15-20% 
somatotrophs, as determined by immunofluores- 
cent staining (J.J. Gomm, personal communica- 
tion). Thus, any changes in [Ca2’], may be masked 
by other cell types present in the preparation. 
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4.2. Effect of quin 2 loading on secretion 
Our results indicate that when pituitary cells are 
loaded with quin 2 there is a slight, but not signifi- 
cant, reduction in basal prolactin secretion, but no 
lowering in the extent of TRH-stimulated prolactin 
secretion over basal. Similar effects have been 
observed using rat pituitary tumour-derived (GH) 
cells by Albert and Tashjian [2] who reported that 
loading cells with quin 2 at intracellular concentra- 
tions up to 0.25 mM had no effect on prolactin 
secretion. Above this level inhibition of basal 
release occurred but THR-stimulated prolactin 
release was unaffected. On the other hand, Ger- 
shengorn and Thaw [ 1,121 found that intracellular 
concentrations of quin 2 up to 1.5 mM had no ef- 
fect on basal or TRH-stimulated prolactin release 
from GHs cells. 
Different effects on basal and stimulated prolac- 
tin secretion have also been observed using 
cultured ovine anterior pituitary cells in the 
presence of ‘low Ca2+’ buffer [ 151. If external 
Ca2+ concentration was lowered to less than 
30pM, basal prolactin secretion was inhibited by 
58%. TRH-stimulated prolactin release was also 
reduced, but the incremental effect of TRH did not 
change significantly [ 151. The similarity between 
this result and the effect obtained with quin 2 sug- 
gests that the latter may act by lowering effective 
Ca2+ levels. 
Both basal and GHRH-stimulated GH secretion 
were greatly reduced, in a dose-dependent manner, 
by loading the pituitary cells with quin 2. A similar 
effect has been observed using blockers of Ca2+ 
uptake [7,13]. Verapamil, CoC12, CdCl2 and also 
pimozide, an inhibitor of Ca2+-calmodulin- 
dependent activities [7] and CoC12 [14] have been 
shown to reduce markedly GHRH-stimulated GH 
secretion from rat anterior pituitary cells. Law [ 161 
also reported the reduction in GHRH-stimulated 
GH secretion to near basal levels when Ca2+ was 
omitted from the extracellular medium. It is in- 
teresting to note that lowering of extracellular 
Ca2+ concentration appeared to enhance GHRH- 
stimulated intracellular cyclic AMP levels [ 161, a 
phenomenon also noted with quin 2-loaded cells 
(unpublished). 
Our data thus suggest hat the ‘Ca’+ buffering’ 
effect of the intracellular quin 2 may affect both 
GH and prolactin secretion from the cells. 
However, quin 2 may alter [Ca2’], in other ways. 
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Thus, a recent report suggests that loading squid 
axons with quin 2 can almost abolish sodium- 
dependent Ca2+ inflow which occurs via Na+/Ca’+ 
exchange 1171. It is also possible that the by- 
products of quin 2/AM hydrolysis (protons, 
acetate and formaldehyde) may affect hormone 
release. 
In conclusion, the quin 2 technique has been 
used to show the effect of TRH, dopamine and 
GHRH on [Ca’+]i using ovine anterior pituitary 
cells. However, loading cells with quin 2 can alter 
both GH and (to a lesser extent) prolactin secretion 
from the cells. The exact method by which it does 
this remains to be established. 
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